Haifeng Qin

The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies

Xiaoqing Liu, Yachao Lu, Guanshan Zhu et al. · Journal of Clinical Pathology · 2013 · 148 citations · Full text

Medicine, Oncology, Pathology +17

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study

Ying Cheng, Qiming Wang, Kai Li et al. · British Journal of Cancer · 2021 · 147 citations · Full text

Medicine, Oncology, Pharmacology +9

<i>FNDC3B</i> circular RNA promotes the migration and invasion of gastric cancer cells via the regulation of E‐cadherin and CD44 expression

Yuling Hong, Haifeng Qin, Yin Li et al. · Journal of Cellular Physiology · 2019 · 118 citations · Full text

Medicine, Molecular Biology, Oncology +16

A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients

Yi Liu, Bing Liu, Xiaoyan Li et al. · Journal of Experimental & Clinical Cancer Research · 2011 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

OA13.03 Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial

Ying Cheng, Q. Wang, K. Li et al. · Journal of Thoracic Oncology · 2018 · 59 citations · Full text

Medicine, Oncology, Pharmacology +9